SNTINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Senti Biosciences Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.23+0.00 (+0.84%)
Close on Oct 19, 2026
- Market cap
- $7.06M
- P/E (TTM)
- –
- Dividend yield
- –
Senti Biosciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Senti Biosciences | Industry median |
|---|---|---|
| Market Cap | $7.06M | $164.85M |
| Enterprise Value | $600.63K | $87.06M |
Income (trailing twelve months)
| Measure | Senti Biosciences | Industry median |
|---|---|---|
| Operating Income | -$54.69M | -$21.44M |
| Net Income | -$49.56M | -$22.46M |
| EBITDA | -$54.69M | -$16.91M |
| EPS (Diluted) | -$1.77 | -$0.83 |
Returns
| Measure | Senti Biosciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -466.5% | -53.1% |
| Return on Assets (ROA) | -97.5% | -41.0% |
| Return on Capital Employed (ROCE) | -315.4% | -37.8% |
Growth
| Measure | Senti Biosciences | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | -82.8% | 2.25% |
Balance sheet
| Measure | Senti Biosciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $6.46M | $62.42M |
| Net Cash (Debt) | $6.46M | $15.68M |
| Net Cash Per Share | $0.21 | $0.66 |
| Equity (Book Value) | -$3.40M | $48.79M |
| Book Value Per Share | -$0.11 | $1.36 |
| Tangible Book Value | -$3.40M | $23.06M |
| Working Capital | -$2.76M | $75.77M |
Financial position
| Measure | Senti Biosciences | Industry median |
|---|---|---|
| Current Ratio | 0.83 | 3.30 |
| Quick Ratio | 0.41 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Senti Biosciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$38.05M | -$12.35M |
Dividends and yields
| Measure | Senti Biosciences | Industry median |
|---|---|---|
| Earnings Yield | -701.7% | -22.7% |
Shares
| Measure | Senti Biosciences | Industry median |
|---|---|---|
| Shares Outstanding | 31,144,800 | 58,179,650 |
| Shares Change (YoY) | 155.4% | 11.1% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Shares Held by Institutions | 6.45% | 59.4% |
Taxes
| Measure | Senti Biosciences | Industry median |
|---|---|---|
| Income Tax | $0 | $91.50K |
Scores
| Measure | Senti Biosciences | Industry median |
|---|---|---|
| Altman Z-Score | -21.32 | -0.24 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Senti Biosciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.